Latest Share Chat

REMOVE ADS

Glaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes

Get Live Data

1,917.00 -21.00 (-1.08%)

Bid:

1,916.50

Ask:

1,917.50

Spread: 1.00 (0.052%)

Market Cap: £76.88b

Last checked at -

Intraday Glaxosmithkline Share Chart

REMOVE ADS

Glaxosmithkline News

GSK gets preliminary nod for two respiratory drugs in Europe

(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agenc...

GSK's Arexvy on track for wider age range approval in Europe

(Alliance News) - GSK PLC on Friday said European regulators have recommended broadening the indication for its Arexvy vaccine to all adults aged 18 a...

LONDON BRIEFING: FTSE 100 to rise, UK GDP down, trade deficit spikes

(Alliance News) - Stocks were called to open higher in London on Friday, as the Office for National Statistics reported that the UK economy unexpected...

GSK's Arexy receives EU green light

(Sharecast News) - GSK said on Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use had recommended expanding th...

IN BRIEF: GSK says US FDA backs supplemental gepotidacin application

GSK PLC - London-based pharmaceuticals firm - US Food & Drug Administration approves a supplemental new drug application for gepotidacin as an oral op...

Outgoing GSK CEO Emma Walmsley declares US best place to invest

(Alliance News) - Outgoing GSK PLC Chief Executive Officer Emma Walmsley has said the US is the best place to invest, in the latest blow to Britain's ...

UK medicine rebate rate to drop in 2026 after US pharma deal

Industry cited record rebate rates as halting investments *

IN BRIEF: GSK small-cell lung cancer drug gets support from US FDA

GSK PLC - London-based pharmaceutical maker - US regulator the Food & Drug Administration grants orphan drug designation to a GSK treatment for small-...